Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Genzyme Transgenics to develop monoclonal antibodies for Centocor

Dec. 11, 1998

Zeneca and Amersham Pharmacia Biotech will collaborate on proteomics research

Dec. 11, 1998

Two NIH grants awarded to Atrix for preclinical studies on Atrigel polymer system

Dec. 11, 1998

CIMA reports significant transmucosal absorption-enhancing effects for OraVescent

Dec. 9, 1998

Major R&D agreement signed by two German companies

Dec. 8, 1998

CuraGen, Glaxo Wellcome initiate collaborative pharmacogenomics-based drug discovery effort

Dec. 7, 1998

Atrix acquires ViroTex and expands drug delivery technology base

Dec. 4, 1998

Isis sublicenses technology for designing improved antisense drugs

Dec. 2, 1998

Novel injectable drug delivery technology in-licensed by Medi-Ject

Dec. 2, 1998

Jenner Biotherapies receives patent on improved vaccine formulation

Dec. 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...